Hovione
Ana Henriques has a diverse work experience in the field of internal audit and business advisory services. Ana is currently working as the Senior Director of Internal Audit at Hovione since September 2022. Prior to this, they held the position of Senior Manager Internal Audit at Visteon Corporation, where they were responsible for leading the global internal audit team and executing the audit plan. Ana also worked as a Manager Internal Audit at Visteon Corporation from May 2017 to June 2019. Before joining Visteon, Ana worked as a Senior Internal Auditor at Cogeco Inc. from September 2012 to April 2017. Ana also worked at Cabovisão as an Internal Control Strategist and at Ernst & Young in various roles, including Senior Consultant in Business Advisory Services and Technology Risk Consultant. Additionally, they have experience as a Financial Auditor at Moore Stephens - Portugal.
Ana Henriques completed their Master's degree in Information Management with a specialization in Knowledge Management and Business Intelligence from NOVA IMS Information Management School between 2019 and 2022. Prior to that, they obtained a Graduate degree in Business Management from ISCTE - Instituto Universitário de Lisboa between 2000 and 2005. Additionally, Ana obtained the certification of Certified Internal Auditor (CIA) from The Institute of Internal Auditors Inc. in 2016. Ana also pursued an Advanced Financial Accounting Specialization from ISCTE - Instituto Universitário de Lisboa starting in 2007, but no end year was provided.
This person is not in any teams
This person is not in any offices
Hovione
2 followers
Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and devices. Hovione´s culture is based on innovation, quality and dependability. Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.